GE Healthcare Speeds Assay Development with Pre-Validated Conditions for GPCR Studies
GE Healthcare, a combination of the former Amersham and GE Medical Systems, is to help further address bottlenecks in the drug discovery process with the introduction of a range of pre-developed protocols for GPCR membranes. These pre-validated protocols offer substantial time-savings of up to 15 days during the GPCR assay development stage.
The new SPA GPCR Assays offer researchers working in high throughput screening environments pre-developed assay conditions for GPCR receptor-ligand binding studies.
"GE Healthcare is continually working to help cut development time throughout the drug discovery process," comments John Sutton, vice president product management, cell analysis & screening at GE Healthcare. "This is the first time that SPA GPCR protocols have been available in this way. By providing ready-made optimum assay conditions for GPCR ligand binding studies, GE Healthcare is reducing assay development process time for researchers, therefore enabling them to focus on screening potential drug candidates."
These SPA GPCR Assays broaden GE Healthcare's SPA range and comprise SPA beads and radioligands from GE Healthcare with GPCR receptor membranes from Euroscreen S.A., as well as a pre-validated protocol describing the required procedure for the GPCR assay.
Other news from the department research and development
These products might interest you

Hydrosart® Ultrafilter by Sartorius
Efficient ultrafiltration for biotech and pharma
Maximum flow rates and minimum protein loss with Hydrosart® membranes

Hydrosart® Microfilter by Sartorius
Hydrophilic microfilters for bioprocesses
Minimal protein adsorption and high flow rates

Sartobind® Rapid A by Sartorius
Efficient chromatography with disposable membranes
Increase productivity and reduce costs with fast cycle times

Sartopore® Platinum by Sartorius
Efficient filtration with minimal protein adsorption
Reduces rinsing volume by 95 % and offers 1 m² filtration area per 10"

Polyethersulfone Ultrafilter by Sartorius
Reliable filtration with PESU membranes
Perfect for biotechnology and pharmaceuticals, withstands sterilisation and high temperatures

Polyethersulfone Microfilter by Sartorius
Biotechnological filtration made easy
Highly stable 0.1 µm PESU membranes for maximum efficiency

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
See the theme worlds for related content
Topic World Cell Analysis
Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.

Topic World Cell Analysis
Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.